GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (WBO:TEVA) » Definitions » 6-1 Month Momentum %

Teva Pharmaceutical Industries (WBO:TEVA) 6-1 Month Momentum % : 0.31% (As of Dec. 15, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Teva Pharmaceutical Industries 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-12-15), Teva Pharmaceutical Industries's 6-1 Month Momentum % is 0.31%.

The industry rank for Teva Pharmaceutical Industries's 6-1 Month Momentum % or its related term are showing as below:

WBO:TEVA's 6-1 Month Momentum % is ranked worse than
54.4% of 1068 companies
in the Drug Manufacturers industry
Industry Median: 0.28 vs WBO:TEVA: 0.31

Competitive Comparison of Teva Pharmaceutical Industries's 6-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teva Pharmaceutical Industries's 6-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's 6-1 Month Momentum % falls into.



Teva Pharmaceutical Industries  (WBO:TEVA) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Teva Pharmaceutical Industries  (WBO:TEVA) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Teva Pharmaceutical Industries 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Teva Pharmaceutical Industries Business Description

Address
124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.